Education
About Us
Working with TipRanks
Follow Us
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 705.92K | $ 464.28K | $ 226.21K | $ 255.40K | $ 722.74K |
| Gross Profit | $ 703.20K | $ 459.46K | $ 194.71K | $ 183.56K | $ 547.39K |
| Operating Income | $ -11.88M | $ -5.75M | $ -6.53M | $ -6.62M | $ -5.69M |
| EBITDA | $ -11.88M | $ -5.68M | $ -6.39M | $ -6.52M | $ -5.54M |
| Net Income | $ -11.90M | $ -5.80M | $ -6.66M | $ -7.27M | $ -4.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.95M | $ 6.56M | $ 1.48M | $ 6.16M | $ 11.75M |
| Total Assets | $ 4.18M | $ 8.87M | $ 3.08M | $ 7.83M | $ 13.27M |
| Total Debt | $ 109.32K | $ 137.37K | $ 163.97K | $ 49.99K | $ 97.32K |
| Net Debt | $ -1.69M | $ -6.36M | $ -1.19M | $ -5.76M | $ -10.82M |
| Total Liabilities | $ 1.57M | $ 1.21M | $ 403.91K | $ 201.44K | $ 203.26K |
| Stockholders' Equity | $ 2.99M | $ 8.04M | $ 3.04M | $ 7.95M | $ 13.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.45M | $ -5.00M | $ -6.05M | $ -5.01M | $ -4.07M |
| Operating Cash Flow | $ -10.45M | $ -4.96M | $ -5.88M | $ -4.88M | $ -3.99M |
| Investing Cash Flow | $ -243.02K | $ -188.60K | $ -169.61K | $ -180.64K | $ 193.88K |
| Financing Cash Flow | $ 6.05M | $ 10.32M | $ 1.59M | $ -44.60K | $ 13.42M |
Lexaria Bioscience Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.